Literature DB >> 14248511

A CONTROLLED STUDY OF FLUPHENAZINE ENANTHATE IN CHRONIC SCHIZOPHRENIC PATIENTS.

C L RAVARIS, L A WEAVER, G W BROOKS.   

Abstract

Entities:  

Keywords:  CLINICAL RESEARCH; DELAYED-ACTION PREPARATIONS; DRUG THERAPY; FLUPHENAZINE; GERIATRICS; INJECTIONS, SUBCUTANEOUS; SCHIZOPHRENIA; SESAME OIL

Mesh：

Substances：

Year:  1965        PMID： 14248511

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN： 0012-3714


× No keyword cloud information.
  7 in total

1.  Effects of fluphenazine enanthate and fluphenazine decanoate on discriminated avoidance response and water drinking behavior in rats.

Authors:  H Kuribara; S Tadokoro
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

2.  Long-acting phenothiazines in schizophrenia.

Authors:  G M Simpson
Journal:  Br Med J       Date:  1971-07-24

3.  A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate.

Authors:  A A Kurland; J H Richardson
Journal:  Psychopharmacologia       Date:  1966

4.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17

Review 5.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 6.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

7.  Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review.

Authors:  Simon Zhornitsky; Emmanuel Stip
Journal:  Schizophr Res Treatment       Date:  2012-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.